J.L. Vizmanos
- Molecular Biology
- Hematology top 5%
- Genetics top 5%
- Rheumatology top 5%
- Cancer Research
- Co-authors
- Francisco J. NovoMarı́a José CalasanzMaría José LarráyozCarlos J. González-NavarroPaula AranazM. García‐DelgadoIdoya LahortigaMaría D. Odero
- Topics
- Acute Myeloid Leukemia Research (13 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers)Chronic Myeloid Leukemia Treatments (9 papers)
- Cited by
- AgingHematologyGenetics
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
J.L. Vizmanos
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 615
- Hematology 316
- Genetics 214
- Rheumatology 164
- Cancer Research 130
Countries citing papers authored by J.L. Vizmanos
This map shows the geographic impact of J.L. Vizmanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Vizmanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Vizmanos more than expected).
Fields of papers citing papers by J.L. Vizmanos
This network shows the impact of papers produced by J.L. Vizmanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Vizmanos. The network helps show where J.L. Vizmanos may publish in the future.
Co-authorship network of co-authors of J.L. Vizmanos
This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Vizmanos. A scholar is included among the top collaborators of J.L. Vizmanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Vizmanos. J.L. Vizmanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 78 | |
| 8 | 21 | |
| 9 | 18 | |
| 10 | 34 | |
| 11 | 7 | |
| 12 | 19 | |
| 13 | 13 | |
| 14 | 35 | |
| 15 | 35 | |
| 16 | 65 | |
| 17 | 24 | |
| 18 | Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL negative chronic myeloproliferative disorders. | 1 |
| 19 | 15 | |
| 20 | 1 |
About J.L. Vizmanos
J.L. Vizmanos is a scholar working on Aging, Hematology and Genetics, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Aging (58 citations), Hematology (316 citations) and Genetics (214 citations). J.L. Vizmanos has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Francisco J. Novo, Marı́a José Calasanz, María José Larráyoz, Carlos J. González-Navarro, Paula Aranaz, M. García‐Delgado, Idoya Lahortiga, María D. Odero, Xabier Agirre and María Isabel Calvo. Their work appears in journals such as Bioinformatics, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.